Specifically, highly expressed in ovarian cancer, KLF5 facilitated the process of ovarian cancer proliferation and metastasis and promoted PARP inhibitor resistance by remodeling the transcription of the key gene for homologous recombination, RAD51 [32]. The gene discussed is RAD51; the disease is ovarian carcinoma.